
As of this writing, Simon Property Group (SPG) carries one of the higher Smart Money Convergence scores on the site: 79.06 out of 100, 11 unique insider buyers, a triggered cluster alert, and +$291.4 million in guru (institutional) net flow. On the surface, that reads like a strong, broad-based conviction signal. Pull the actual filings behind those numbers, though, and the story is more specific -- and more instructive -- than the headline score alone suggests.
All 11 of SPG's "unique insider buyers" are directors, and every single one of them bought on the exact same date: June 30, 2026. The share counts are small -- 2 shares here, 41 shares there, the largest single line item just 430 shares -- at nearly identical prices clustered between $223.10 and $225.03. Add it up across all 11 people and you get a pattern that looks less like 11 independent executives each deciding, on their own, to bet on the stock, and more like a routine, scheduled mechanism -- the kind of thing that happens when board compensation is partly paid in stock, or a dividend-reinvestment arrangement runs on a fixed date for every director at once.
That doesn't make the purchases meaningless -- directors are still putting personal capital into the stock, and 11 people opting into that arrangement rather than taking cash is still information. But it's a meaningfully different story than "11 executives independently decided this was a buying opportunity," which is the impression a bare confidence score can leave if you stop at the headline number.
The recent-trades data also includes exactly one sale: SPG's Chief Administrative Officer sold 10,000 shares at $200.88 (roughly $2.01 million) back on February 25, 2026. That single officer sale is larger in dollar terms than any individual director's June purchase -- worth knowing if you're weighing the insider picture as a whole rather than just counting buy-side line items.
Take director Stefan M Selig's June 30 trades as a representative example: 187 shares at $223.14 ($41,727), then a second line of 33 shares at $224.01 ($7,392) the same day. Two separate transaction lines, same day, same person, prices a few cents apart -- the kind of split that shows up when an order fills in more than one execution, not two separate investment decisions. Every one of the other 10 directors shows the same shape: one larger line plus one smaller line, same date, prices within a dollar or two of each other. That internal consistency across 11 unrelated people is itself a clue -- it's much easier to explain as one coordinated process (executed slightly differently per person depending on exact share entitlements) than as 11 people independently timing the market to within the same afternoon.
To be clear about what we can and can't know from the filings alone: Form 4 doesn't disclose why a transaction happened, only that it did, so this is an inference from the pattern (identical date, tightly clustered prices, small and irregular share counts, all-director composition), not a confirmed mechanism. But it's a reasonable enough inference that treating this specifically as "11 independent conviction buys" would overstate what the data supports.
Zoom out to SPG's 13F data and a fuller (and genuinely more interesting) picture emerges. As of the latest reporting period:
That last breakdown matters: even in a stock institutions are net accumulating, hundreds of managers are simultaneously trimming or exiting entirely. "Institutions are buying SPG" is true in aggregate and also an oversimplification of what's actually a mixed, ongoing reallocation across more than a thousand separate decision-makers.
This is where it gets genuinely useful. SPG's top holders by dollar value are exactly who you'd expect for any large, widely-held U.S. stock: BlackRock ($6.87 billion, a modest 0.12% of BlackRock's own total book), Vanguard Portfolio Management ($4.31 billion), State Street ($3.90 billion), Vanguard Capital Management ($3.84 billion), and Geode Capital Management ($2.01 billion). These are index-tracking giants -- their SPG position is large in absolute dollars purely because they're enormous, not because SPG is a concentrated conviction bet for them.
Ranked by conviction instead -- how much of their own portfolio a manager has committed to SPG -- a completely different set of names surfaces: Resolution Capital Ltd at 7.84% of its entire disclosed portfolio, Smead Capital Management at 6.33%, Hamlin Capital Management at 4.04%, CBRE Investment Management (Listed Real Assets) at 3.34%, and CenterSquare Investment Management at 2.70%. These are smaller, real-estate-focused specialist managers -- firms whose entire mandate is picking REITs and property-sector equities -- putting a meaningfully larger share of their actual book behind SPG specifically.
If you're trying to gauge genuine institutional conviction rather than just "who owns the most dollars," the conviction list is the more informative one -- specialist managers concentrating a real estate position in a real estate stock tells you something that a mega-index-fund's proportionally tiny stake doesn't.
None of this makes SPG's Smart Money Convergence entry fake or unimportant -- $291.4 million of net institutional buying is real money, and 11 directors choosing stock over cash is still a data point. But the headline "79/100, 11 buyers, cluster alert" reads more dramatically than the underlying mechanism (a same-day, small-denomination director purchase pattern) actually supports on its own. The genuinely richer story is in the 13F detail underneath it: a stock institutions are net accumulating but far from unanimously, held in bulk by index giants who barely notice it and in concentration by real-estate specialists who very much do.
This is exactly the kind of digging our Smart Money Convergence and Form 4 guides describe in the abstract -- a convergence score is a place to start looking, not a conclusion to stop at.
Does any of this mean SPG is a good or bad investment right now? This article isn't investment advice, and nothing here should be read as a buy or sell recommendation -- the point is narrower: showing what the data underneath a headline convergence score actually contains, using SPG as a live, real example.
If the director purchases are mechanical, is the Smart Money Convergence signal broken for this stock? Not broken -- just worth reading with the added context above. The $291.4 million in institutional net flow and the specialist managers' concentrated positions are independent of the director-purchase mechanism and stand on their own. The signal correctly flagged a stock with real institutional accumulation; it's the "11 unique buyers" framing specifically that benefits from this extra layer of digging.
Why look at conviction-ranked holders instead of just the biggest dollar positions? Because the biggest dollar positions are, for almost any large-cap stock, dominated by the same handful of index-tracking giants (BlackRock, Vanguard, State Street) whose size reflects their own scale, not a specific view on the company. Conviction ranking surfaces the managers who made an active, comparatively concentrated choice -- a more informative signal about what specialists actually think of the stock.
SPG's Smart Money Convergence score is real, but the story behind it is more nuanced than the number alone suggests: a same-day, small-scale director purchase pattern that looks mechanical rather than independently discretionary, one larger officer sale that doesn't show up in a "buyers" count, and a 13F base where the real conviction sits with specialist real-estate managers rather than the index funds holding the most absolute dollars. Data as of July 29, 2026 -- check the live pages linked above for anything more recent.
Elevance Health's institutional base has been shrinking for two years straight. Its CEO has bought stock repeatedly anyway -- most recently just days before this data was pulled.
KKR & Co carries an 80/100 Smart Money Convergence score. Zoom into the actual dates and the underlying institutional flow, and a very different, more time-sensitive picture appears.
Institutional 13F buying and company-insider Form 4 buying rarely point at the same stock at once. When they do, it's called convergence -- here's what it means and how to read it.